Brilliant Violet 650™ anti-human CD152 (CTLA-4) Antibody, CD152, BNI3

Pricing & Availability

Clone: BNI3 (See other available formats)
Regulatory Status: RUO
Other Names: CTLA4, Cytotoxic T-Lymphocyte Antigen 4, CTLA-4
Isotype: Mouse IgG2a, κ
Ave. Rating: Submit a Review
Product Citations: publications

BNI3_BV-650_CD152_FC_031324 — Human peripheral blood mononuclear cells were stimulated with Cell Activation Cocktail (without Brefeldin A) (Cat. No. 423302) for 4 hours and, surface stained with anti-human CD3 (clone UCHT-1) PE. Cells were then fixed and permeabilized with Cyto-Fast™ Fix/Perm Buffer Set (Cat. No. 426803), and intracellularly stained with anti-human CD152 (CTLA-4) (clone BNI3) Brilliant Violet 650™ (left), or mouse IgG2a, κ Brilliant Violet 650™ isotype control (right).

Compare all formats See Brilliant Violet 650™ spectral data

Cat #

Size

Price

Quantity Check Availability

Save

369647

25 tests

177€

Check Availability

Need larger quantities of this item?
Request Bulk Quote

369648

100 tests

348€

Check Availability

Need larger quantities of this item?
Request Bulk Quote

Description

CD152, also known as Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), is a 33 kD member of the immunoglobulin superfamily. It is transiently expressed on activated T cells. CTLA-4 is expressed on the surface of helper T cells and transmits an inhibitory signal to T cells. Regulatory T cells express high levels of CTLA-4. CTLA-4 (CD152) is similar to CD28 in amino acid sequence, structure, and genomic organization. Whereas CD28 delivers a costimulatory signal in T cell activation, CTLA-4 negatively regulates cell-mediated immune responses through interaction with CD80 (B7-1) and CD86 (B7-2) present on antigen presenting cells (APC). CTLA-4 is thought to play a role in the induction and maintenance of immunological tolerance as well as the development of protective immunity and thymocyte regulation.

Mutations in the CTLA-4 gene have been associated with various autoimmune diseases, such as systemic lupus erythematosus, insulin-dependent diabetes mellitus, and other autoimmune diseases. A transcript of the CTLA-4 gene that may represent a native soluble form of CTLA-4 (sCTLA-4) showed that eleven of twenty patients with autoimmune thyroid disease (ATD) had a high concentration of sCTLA-4, whereas only 1 of 30 apparently healthy volunteers contained measurable levels. sCTLA-4 immunoreactivity was inhibited by its binding to B7.1, suggesting that sCTLA-4 is a functional receptor. sCTLA-4 also plays a role in the initial immune response to infection of immune cells by HIV, along with the CD-1 pathway and others.

Product Details

Technical data sheet

Product Details

Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Extracellular domain of human CTLA-4 and constant regions of the human IgG heavy chain (CTLA-4/IgG)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 650™ under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality tested
FC - Verified
Recommended Usage: Each lot of this antibody is quality control tested by intracellular flow cytometry using our Cyto-Fast™ Fix/Perm Buffer Set. For flow cytometric staining, the suggested use of this reagent is 5 µL per 10⁶ cells in 100 µL volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 650™ excites at 405 nm and emits at 645 nm. The bandpass filter 660/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 650™ is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser: Violet Laser (405 nm)
Application Notes: Based on in-house testing, we do not recommend using clone BNI3 for immunohistochemistry of paraffin-embedded tissue section.
RRID: AB_3106114 (BioLegend Cat. No. 369647)
AB_3106114 (BioLegend Cat. No. 369648)

Antigen Details

Structure: Ig superfamily and 33 kD.
Distribution: Activated T cells and B cells.
Function: Negative regulator of T cell activation.
Interaction: Antigen presenting cells, such as dendritic cells.
Ligand/Receptor: B7-1 (CD80), B7-2 (CD86).
Cell Type: B cells, T cells
Biology Area: Immunology, Inhibitory Molecules
Molecular Family: CD Molecules, Immune Checkpoint Receptors
Antigen References: 1. Kuiper HM, et al. 1995. J. Immunol. 155:1776.
2. Castan J, et al. 1997. Immunology 90:265.
3. Lee CC, et al. 2009. Pediatr. Allergy Immunol. 20:624.
4. Pistillo MP, et al. 2003. Blood 101:202.
5. Tan PH, et al. 2005. Blood. 106:2936.
6. Steiner K, et al. 2001. Clin. Exp. Immunol. 126:143.
Gene ID: 1493 View all products for this Gene ID
UniProt: View information about CD152 on UniProt.org

Documentation

Reviews

Review This Product

Related Protocols

Related Products

Description	Clone	Applications

Related Pages & Pathways

Pathways

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD152 Reagents Request Custom Conjugation

Description	Clone	Applications
Purified anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Brilliant Violet 421™ anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Brilliant Violet 605™ anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PerCP/Cyanine5.5 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Biotin anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
APC anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE/Cyanine7 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE/Dazzle™ 594 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
TotalSeq™-A0151 anti-human CD152 (CTLA-4)	BNI3	PG
TotalSeq™-C0151 anti-human CD152 (CTLA-4)	BNI3	PG
Brilliant Violet 785™ anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
TotalSeq™-B0151 anti-human CD152 (CTLA-4)	BNI3	PG
APC/Fire™ 750 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Alexa Fluor® 647 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
APC/Cyanine7 anti-human CD152 (CTLA-4) Antibody	BNI3	ICFC,FC
Brilliant Violet™ 711 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
TotalSeq™-D0151 anti-human CD152 (CTLA-4)	BNI3	PG
PE/Fire™ 640 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Spark Red™ 718 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE/Cyanine5 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE/Fire™ 744 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
PE/Fire™ 810 anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Brilliant Violet 650™ anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Brilliant Violet 510™ anti-human CD152 (CTLA-4)	BNI3	ICFC,FC
Spark Blue™ 574 anti-human CD152 (CTLA-4) (Flexi-Fluor™)	BNI3	FC
Spark Blue™ 550 anti-human CD152 (CTLA-4) (Flexi-Fluor™)	BNI3	FC

Certificate of Analysis

Customers Also Purchased

Purified anti-mouse I-A/I-E

Clone: M5/114.15.2

Recombinant Mouse IL-2 (carrier-free)

Recombinant Human M-CSF (carrier-free)

Spark PLUS UV395™ anti-human CD45RA

Clone: HI100

Go To Top Version: 2 Revision Date: 07.24.2024

For Research Use Only. Not for diagnostic or therapeutic use.

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.